TargeGen targegen.com


TargeGen, a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular leakage, vascular proliferation, and inflammation.

TargeGen, a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular leakage, vascular proliferation, and inflammation.

Company (Acquired)

Phone: 858-678-0760

Fax:

9380 Judicial Drive

San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
TargeGen $103.7M Jun 30, 2010
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related TargeGen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 16 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Heterocyclic compounds and methods of use Sep 23, 2011 Feb 12, 2013 Patent
Heterocyclic compounds and methods of use Jan 08, 2010 Dec 27, 2011 Patent
Kinase inhibitors and methods of use thereof Apr 25, 2007 Apr 06, 2010 Patent
Heterocyclic compounds and methods of use Aug 24, 2005 Jan 26, 2010 Patent
Compositions and methods for treating myelofibrosis May 06, 2013 Application
See all 7 patents